Clinical trial
Urinary PGE-M, A Metabolite of PGE2: A Novel Biomarker of Ulcerative Colitis Disease
NCT00409396 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Urinary PGE-M, A Metabolite of PGE2: A Novel Biomarker of Ulcerative Colitis Disease
- Lead sponsor
- Vanderbilt University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2006
- Completion date
- December 31, 2007
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ulcerative colitis